Healthy Returns: Biotech IPOs heated up, but haven't fully recovered
Biotech IPOs surged at the start of 2024, but the rest of the year will depend on Fed rate cuts. Meanwhile, doctors using VR and AI to hone their skills.
Stay updated with breaking news from Arda Ural. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biotech IPOs surged at the start of 2024, but the rest of the year will depend on Fed rate cuts. Meanwhile, doctors using VR and AI to hone their skills.
Last week, Nvidia (NASDAQ:NVDA) announced deals with Johnson & Johnson (NYSE:JNJ) for use of generative AI in surgery, and with GE Healthcare (NYSE:GE) to improve medical imaging. The health care developments at its 2024 GTC AI conference, — which also ...
(CTN News) - In addition, NVIDIA announced deals with Johnson & Johnson and GE Healthcare for generative AI in surgery. As NVIDIA...............
Last week, Nvidia (NASDAQ:NVDA) announced deals with Johnson & Johnson (NYSE:JNJ) for use of generative AI in surgery, and with GE Healthcare (NYSE:GE) to improve medical imaging. The health care developments at its 2024 GTC AI conference, — which also ...
Fast-approaching patent expirations will take a bite out of revenues and put the industry's top players in the hot seat over the next few years.